Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, Doximity Inc (NYSE: DOCS) closed at $43.86 up 0.16% from its previous closing price of $43.79. In other words, the price has increased by $0.16 from its previous closing price. On the day, 2.05 million shares were traded. DOCS stock price reached its highest trading level at $44.05 during the session, while it also had its lowest trading level at $42.66.
Ratios:
For a deeper understanding of Doximity Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.40 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 26.46. For the most recent quarter (mrq), Quick Ratio is recorded 7.75 and its Current Ratio is at 7.75. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In the most recent recommendation for this company, RBC Capital Mkts on January 09, 2026, initiated with a Outperform rating and assigned the stock a target price of $59.
Morgan Stanley Upgraded its Equal-Weight to Overweight on December 15, 2025, while the target price for the stock was maintained at $65.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 02 ’26 when Wampler Kira Scherer sold 2,000 shares for $44.65 per share. The transaction valued at 89,300 led to the insider holds 19,839 shares of the business.
KIRA WAMPLER bought 2,000 shares of DOCS for $89,300 on Jan 02 ’26. On Dec 01 ’25, another insider, Wampler Kira Scherer, who serves as the Director of the company, sold 2,000 shares for $50.71 each. As a result, the insider received 101,420 and left with 19,839 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DOCS now has a Market Capitalization of 8257577984 and an Enterprise Value of 7390479872. As of this moment, Doximity’s Price-to-Earnings (P/E) ratio for their current fiscal year is 34.98, and their Forward P/E ratio for the next fiscal year is 25.42. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.33. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.29 while its Price-to-Book (P/B) ratio in mrq is 7.53. Its current Enterprise Value per Revenue stands at 11.895 whereas that against EBITDA is 29.076.
Stock Price History:
The Beta on a monthly basis for DOCS is 1.39, which has changed by -0.13748276 over the last 52 weeks, in comparison to a change of 0.19226205 over the same period for the S&P500. Over the past 52 weeks, DOCS has reached a high of $85.21, while it has fallen to a 52-week low of $43.21. The 50-Day Moving Average of the stock is -10.81%, while the 200-Day Moving Average is calculated to be -25.12%.
Shares Statistics:
For the past three months, DOCS has traded an average of 2.34M shares per day and 2553080 over the past ten days. A total of 137.19M shares are outstanding, with a floating share count of 133.55M. Insiders hold about 29.06% of the company’s shares, while institutions hold 66.16% stake in the company. Shares short for DOCS as of 1767139200 were 8597827 with a Short Ratio of 3.67, compared to 1764288000 on 5556952. Therefore, it implies a Short% of Shares Outstanding of 8597827 and a Short% of Float of 6.4.
Earnings Estimates
A detailed examination of Doximity Inc (DOCS) is currently in progress, with 18.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $0.32, with high estimates of $0.39 and low estimates of $0.26.
Analysts are recommending an EPS of between $1.67 and $1.35 for the fiscal current year, implying an average EPS of $1.57. EPS for the following year is $1.72, with 19.0 analysts recommending between $2.04 and $1.47.
Revenue Estimates
A total of 19 analysts believe the company’s revenue will be $181.58M this quarter.It ranges from a high estimate of $192.21M to a low estimate of $180M. As of. The current estimate, Doximity Inc’s year-ago sales were $168.6MFor the next quarter, 19 analysts are estimating revenue of $150.51M. There is a high estimate of $158.71M for the next quarter, whereas the lowest estimate is $147.8M.
A total of 20 analysts have provided revenue estimates for DOCS’s current fiscal year. The highest revenue estimate was $664.29M, while the lowest revenue estimate was $625M, resulting in an average revenue estimate of $645.32M. In the same quarter a year ago, actual revenue was $570.4MBased on 20 analysts’ estimates, the company’s revenue will be $717.44M in the next fiscal year. The high estimate is $773.46M and the low estimate is $688.7M.
